Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 24Recruiting 9Unknown 8Terminated 2Not yet recruiting 2No longer available 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 65Breast 16Head & Neck 11Tumor-Agnostic 2Thoracic 2Other solid neoplasm 2CNS 1

Conditions

MSI-H Colorectal Cancer 1Advanced Solid Tumor 1

Interventions

Injections 9Interviews as Topic 4Cisplatin 4Carboplatin 4toripalimab 3fludarabine 3envafolimab 3Pemetrexed 3Iodine-125 3Immune Checkpoint Inhibitors 3Fluorodeoxyglucose F18 3tislelizumab 2pembrolizumab 2Paclitaxel 2Oxaliplatin 2Drug Therapy 2Cyclophosphamide 2Cryosurgery 2Capecitabine 2Blood Specimen Collection 2trastuzumab deruxtecan 1spartalizumab 1somatostatin receptor 2 1regorafenib 1olaparib 1nabiximols 1malic acid 1lenvatinib 1ivarmacitinib 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Capecitabine × Other solid neoplasm × Clear all
NCT06446388 2024-06-06

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 2 Not yet recruiting
360 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05841134 2023-05-09

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting
25 enrolled
GastrointestinalOther solid neoplasm

MSI-H Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡